A Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of a Human Menopausal Gonadotropin in the Development of Multiple Follicles, Pregnancy, and Cumulative Live Birth as Part of an Assisted Reproductive Technology (ART) Cycle.

Inclusion Criteria: * Pre-menopausal women aged 18-42 years old at the time of consent. * BMI ≥18 and \<38 kg/m² at the time of consent. * Menstrual cycles between 21-35 days. * Normal mammogram or breast ultrasound if patient is \>40 or if participant is younger as indicated by physician recommendation, within 2 years of screening. * Anti-Müllerian hormone (AMH) \>1.2 ng/ml within 6 months of screening. * If donor sperm is used, donor must be 18-40 years of age at the time of collection and compliant with 21 Code of Regulations (CFR) section 1271 Subpart C. * Transvaginal ultrasound (TVUS) d…